2-氨基-1-环己烯-1-甲酸乙酯 | 1128-00-3

• 物质功能分类: 化学试剂 - 有机试剂 - 烯烃（环状与无环状）
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 乙烯基酰胺
• 中文名称: 2-氨基-1-环己烯-1-甲酸乙酯
• 中文别名: 2-氨基-1-环己烯-1-羧酸乙酯
• 英文名称: ethyl 2-aminocyclohex-1-ene-1-carboxylate
• 英文别名: 2-aminocyclohex-1-enecarboxylic acid ethyl ester；ethyl 2-aminocyclohex-1-enecarboxylate；ethyl 2-aminocyclohexene-1-carboxylate；Ethyl 2-amino-1-cyclohexene-1-carboxylate
• CAS: 1128-00-3
• 化学式: C₉H₁₅NO₂
• mdl: MFCD01863243
• 分子量: 169.224
• InChiKey: JBZVWABPSHNPIK-UHFFFAOYSA-N

物化性质

• 熔点：
  70-74 °C
• 沸点：
  298.52°C (rough estimate)
• 密度：
  1.0873 (rough estimate)
• 稳定性/保质期：
  避免光照。

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.666
• 拓扑面积：
  52.3
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 安全说明：
  S24/25
• 海关编码：
  2922499990
• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H302
• 储存条件：
  密封储存，应存放在阴凉、干燥的库房中。

SDS

Name:	Ethyl 2-amino-1-cyclohexene-1-carboxylate 98% Material Safety Data Sheet
Synonym:	None Known
CAS:	1128-00-3

Section 1 - Chemical Product MSDS Name:Ethyl 2-amino-1-cyclohexene-1-carboxylate 98% Material Safety Data Sheet
Synonym:None Known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
1128-00-3	Ethyl 2-amino-1-cyclohexene-1-carboxyl	98%	unlisted

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Light sensitive.The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: In case of contact, immediately flush eyes with plenty of water for at least 15 minutes. Get medical aid.
Skin:
In case of contact, flush skin with plenty of water. Remove contaminated clothing and shoes. Get medical aid if irritation develops and persists. Wash clothing before reuse.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious person. Get medical aid.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing.
Keep container tightly closed. Avoid ingestion and inhalation. Store protected from light.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Store protected from light.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 1128-00-3: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystals
Color: white to light yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 70 - 74 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: soluble in ether, chloroform, ethanol
Specific Gravity/Density:
Molecular Formula: NH2C6H8COOCH2CH3
Molecular Weight: 169.22

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Light sensitive.
Conditions to Avoid:
Light, dust generation.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 1128-00-3 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Ethyl 2-amino-1-cyclohexene-1-carboxylate - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 1128-00-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 1128-00-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1128-00-3 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-氨基-1-环己烯-1-甲酸乙酯 在 盐酸 、 甲醇 、 乙醇 、 水 、 sodium methylate 、 sodium ethanolate 、 镍 、 三氯氧磷 作用下， 生成 5,6,7,8-四氢喹啉
  参考文献：
  名称：

  环烯基吡啶。（3. Mitteilung）。吡咯烷酮和Bz-四氢可可脂

  摘要：

  DOI：

  10.1002/hlca.6602801233
• 作为产物：
  描述：

  2-环己酮甲酸乙酯 在 ammonium acetate 作用下， 以 甲醇 为溶剂， 反应 48.0h， 生成 2-氨基-1-环己烯-1-甲酸乙酯
  参考文献：
  名称：

  使用二氯化碘苯和叠氮化钠直接由1,3-二元醇或3-氨基醇直接合成恶唑烷酮-2-酮和咪唑啉酮-2-酮

  摘要：

  使用碘代二氯二苯甲烷（PhICl 2）和叠氮化钠的相同试剂组合，开发了一种直接，直接由1,3-二醇和3-氨基醇合成恶唑烷-2-酮和咪唑啉-2-酮的通用有效方法。（NaN 3）。

  DOI：

  10.1002/adsc.201300982

文献信息

• Anti-infective agents
  申请人：——

  公开号：US20040087577A1

  公开（公告）日：2004-05-06

  Compounds having the formula 1 are hepatitis C (HCV) polymerase inhibitors. Also disclosed are a composition and method for inhibiting hepatitis C (HCV) polymerase, processes for making the compounds, and synthetic intermediates employed in the processes.

  具有公式1的化合物是丙型肝炎（HCV）聚合酶抑制剂。还公开了一种用于抑制丙型肝炎（HCV）聚合酶的组成和方法，用于制造这些化合物的过程，以及在这些过程中使用的合成中间体。
• Iridium complex-linked porous organic polymers for recyclable, broad-scope photocatalysis of organic transformations
  作者：Zi-Yue Xu、Yi Luo、Dan-Wei Zhang、Hui Wang、Xing-Wen Sun、Zhan-Ting Li

  DOI：10.1039/c9gc03688a

  日期：——

  Two rigid porous organic polymers (Ir-POP-1 and Ir-POP-2) were prepared from the coupling reactions of tetraphenylmethane tetraborate and two [Ir(ppy)2(dtbbpy)]+-based bitopic linkers and applied as heterogeneous visible-light photocatalysts for organic transformations. Ir-POP-2 was found to exhibit high catalytic activity for a wide range of organic reactions, which include Smiles–Truce rearrangement

  由四苯基甲烷四硼酸酯和两个基于[Ir（ppy）2（dtbbpy）+的双位连接基的偶联反应制备了两种刚性多孔有机聚合物（Ir-POP-1和Ir-POP-2），并用作异质的可见-用于有机转化的轻型光催化剂。Ir-POP-2被发现对广泛的有机反应具有高催化活性，其中包括碘化物的Smiles–Truce重排，迈克尔受体的脱硫共轭物加成以及硫化物和芳基硼​​酸的好氧氧化。对于所有转换，Ir-POP-2可以实现与均质原型铱配合物相媲美的异质光催化效率。这种显着高的光催化性能归因于共轭骨架的大孔径。新的非均相光催化剂还非常稳定，可以为所有研究的反应实现良好的可回收性，并且可以重复使用八到十九次。
• Niacin receptor agonists, compositions containing such compounds and methods of treatment
  申请人：Raghavan Subharekha

  公开号：US20060293364A1

  公开（公告）日：2006-12-28

  The present invention encompasses compounds of Formula I: as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating atherosclerosis, dyslipidemias and the like. Pharmaceutical compositions and methods of use are also included.

  本发明涵盖了Formula I的化合物： 以及其药用可接受的盐和水合物，用于治疗动脉粥样硬化、血脂异常等疾病。药物组合物和使用方法也包括在内。
• Tetrahydroquinazolinone Derivatives as PARP Inhibitors
  申请人：Lupin Limited

  公开号：US20150152118A1

  公开（公告）日：2015-06-04

  Disclosed are compounds of formula (I), their tautomeric forms, stereoisomers, and pharmaceutically acceptable salts thereof, wherein R 1 -R 6 , R 7a-d , R 8a-d , A, M, n, and p are as defined in the specification, pharmaceutical compositions including a compound, tautomer, stereoisomer, or salt thereof, and methods of treating or preventing diseases or disorders, for example, cancer, that are amenable to treatment or prevention by inhibiting the PARP enzyme of a subject.

  公开了式（I）的化合物，其互变异构体、立体异构体和其药学上可接受的盐，其中R1-R6、R7a-d、R8a-d、A、M、n和p如规范中所定义，包括一种化合物、互变异构体、立体异构体或其盐的药物组合物，以及治疗或预防疾病或紊乱的方法，例如癌症，这些疾病或紊乱可通过抑制受试者的PARP酶来治疗或预防。
• Visible Light Mediated Aryl Migration by Homolytic C−N Cleavage of Aryl Amines
  作者：Dirk Alpers、Kevin P. Cole、Corey R. J. Stephenson

  DOI：10.1002/anie.201806659

  日期：2018.9.10

  The photocatalytic preparation of aminoalkylated heteroarenes from haloalkylamides via a 1,4‐aryl migration from nitrogen to carbon, conceptually analogous to a radical Smiles rearrangement, is reported. This method enables the substitution of amino groups in heteroaromatic compounds with aminoalkyl motifs under mild, iridium(III)‐mediated photoredox conditions. It provides rapid access to thienoazepinone

  据报道，从卤代烷基酰胺光催化制备1,4-芳基从氮到碳的氨基烷基化杂芳基，概念上类似于自由基的Smiles重排。这种方法可以在温和的铱（III）介导的光氧化还原条件下用氨基烷基基序取代杂芳族化合物中的氨基。它提供了对噻吩并ze庚酮的快速访问，噻吩并ze庚酮是存在于多种候选药物中的一种药效基团，可用于治疗各种疾病，包括炎症和精神病。